368 related articles for article (PubMed ID: 32798273)
1. Lipid accumulation in macrophages confers protumorigenic polarization and immunity in gastric cancer.
Luo Q; Zheng N; Jiang L; Wang T; Zhang P; Liu Y; Zheng P; Wang W; Xie G; Chen L; Li D; Dong P; Yuan X; Shen L
Cancer Sci; 2020 Nov; 111(11):4000-4011. PubMed ID: 32798273
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer cell debris diminishes therapeutic efficacy through heme oxygenase-1-mediated inactivation of M1-like tumor-associated macrophages.
Kim SH; Saeidi S; Zhong X; Gwak SY; Muna IA; Park SA; Kim SH; Na HK; Joe Y; Chung HT; Kim KE; Han W; Surh YJ
Neoplasia; 2020 Nov; 22(11):606-616. PubMed ID: 33039895
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
4. miR-498 inhibits autophagy and M2-like polarization of tumor-associated macrophages in esophageal cancer via MDM2/ATF3.
Li D; Yan M; Sun F; Song J; Hu X; Yu S; Tang L; Deng S
Epigenomics; 2021 Jul; 13(13):1013-1030. PubMed ID: 34114479
[TBL] [Abstract][Full Text] [Related]
5. Macrophage Polarization States in the Tumor Microenvironment.
Boutilier AJ; Elsawa SF
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209703
[TBL] [Abstract][Full Text] [Related]
6. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.
La Fleur L; Botling J; He F; Pelicano C; Zhou C; He C; Palano G; Mezheyeuski A; Micke P; Ravetch JV; Karlsson MCI; Sarhan D
Cancer Res; 2021 Feb; 81(4):956-967. PubMed ID: 33293426
[TBL] [Abstract][Full Text] [Related]
7. Bi- and tri-valent T cell engagers deplete tumour-associated macrophages in cancer patient samples.
Scott EM; Jacobus EJ; Lyons B; Frost S; Freedman JD; Dyer A; Khalique H; Taverner WK; Carr A; Champion BR; Fisher KD; Seymour LW; Duffy MR
J Immunother Cancer; 2019 Nov; 7(1):320. PubMed ID: 31753017
[TBL] [Abstract][Full Text] [Related]
8.
Hu L; Liu Y; Kong X; Wu R; Peng Q; Zhang Y; Zhou L; Duan L
Front Immunol; 2021; 12():658681. PubMed ID: 34093546
[No Abstract] [Full Text] [Related]
9. Targeting the STING pathway in tumor-associated macrophages regulates innate immune sensing of gastric cancer cells.
Miao L; Qi J; Zhao Q; Wu QN; Wei DL; Wei XL; Liu J; Chen J; Zeng ZL; Ju HQ; Luo HY; Xu RH
Theranostics; 2020; 10(2):498-515. PubMed ID: 31903134
[No Abstract] [Full Text] [Related]
10. M2 polarization of tumor-associated macrophages is dependent on integrin β3 via peroxisome proliferator-activated receptor-γ up-regulation in breast cancer.
Shu Y; Qin M; Song Y; Tang Q; Huang Y; Shen P; Lu Y
Immunology; 2020 Aug; 160(4):345-356. PubMed ID: 32311768
[TBL] [Abstract][Full Text] [Related]
11. Codonopsis pilosula-derived glycopeptide dCP1 promotes the polarization of tumor-associated macrophage from M2-like to M1 phenotype.
Liu H; Yao M; Ren J
Cancer Immunol Immunother; 2024 May; 73(7):128. PubMed ID: 38743074
[TBL] [Abstract][Full Text] [Related]
12. Remodeling tumor immune microenvironment via targeted blockade of PI3K-γ and CSF-1/CSF-1R pathways in tumor associated macrophages for pancreatic cancer therapy.
Li M; Li M; Yang Y; Liu Y; Xie H; Yu Q; Tian L; Tang X; Ren K; Li J; Zhang Z; He Q
J Control Release; 2020 May; 321():23-35. PubMed ID: 32035193
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive intestinal peptide represses activation of tumor-associated macrophages in gastric cancer via regulation of TNFα, IL-6, IL-12 and iNOS.
Chen L; Yuan W; Chen Z; Wu S; Ge J; Chen J; Chen Z
Int J Oncol; 2015 Oct; 47(4):1361-70. PubMed ID: 26314485
[TBL] [Abstract][Full Text] [Related]
14. The FBW7-MCL-1 axis is key in M1 and M2 macrophage-related colon cancer cell progression: validating the immunotherapeutic value of targeting PI3Kγ.
Lee YS; Song SJ; Hong HK; Oh BY; Lee WY; Cho YB
Exp Mol Med; 2020 May; 52(5):815-831. PubMed ID: 32444799
[TBL] [Abstract][Full Text] [Related]
15. Phagocytic function of tumor-associated macrophages as a key determinant of tumor progression control: a review.
Lecoultre M; Dutoit V; Walker PR
J Immunother Cancer; 2020 Dec; 8(2):. PubMed ID: 33335026
[TBL] [Abstract][Full Text] [Related]
16. Cordyceps militaris polysaccharide converts immunosuppressive macrophages into M1-like phenotype and activates T lymphocytes by inhibiting the PD-L1/PD-1 axis between TAMs and T lymphocytes.
Bi S; Huang W; Chen S; Huang C; Li C; Guo Z; Yang J; Zhu J; Song L; Yu R
Int J Biol Macromol; 2020 May; 150():261-280. PubMed ID: 32044366
[TBL] [Abstract][Full Text] [Related]
17. MDM2 inhibitor APG-115 synergizes with PD-1 blockade through enhancing antitumor immunity in the tumor microenvironment.
Fang DD; Tang Q; Kong Y; Wang Q; Gu J; Fang X; Zou P; Rong T; Wang J; Yang D; Zhai Y
J Immunother Cancer; 2019 Nov; 7(1):327. PubMed ID: 31779710
[TBL] [Abstract][Full Text] [Related]
18. Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer.
He S; Song W; Cui S; Li J; Jiang Y; Chen X; Peng L
Cell Oncol (Dordr); 2023 Dec; 46(6):1731-1746. PubMed ID: 37402945
[TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophages secrete CC-chemokine ligand 2 and induce tamoxifen resistance by activating PI3K/Akt/mTOR in breast cancer.
Li D; Ji H; Niu X; Yin L; Wang Y; Gu Y; Wang J; Zhou X; Zhang H; Zhang Q
Cancer Sci; 2020 Jan; 111(1):47-58. PubMed ID: 31710162
[TBL] [Abstract][Full Text] [Related]
20. RETRACTED: PINK1 deficiency in gastric cancer compromises mitophagy, promotes the Warburg effect, and facilitates M2 polarization of macrophages.
Xu Y; Lu J; Tang Y; Xie W; Zhang H; Wang B; Zhang S; Hou W; Zou C; Jiang P; Zhang W
Cancer Lett; 2022 Mar; 529():19-36. PubMed ID: 34979165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
